Cargando…
Brain-Gut Interactions in IBS
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with an estimated prevalence of 10–20%. Current understanding of the pathophysiology of IBS is incomplete due to the lack of a clearly identified pathological abnormality and due to the lack of reliable biomarkers. Possible mechani...
Autores principales: | Fichna, Jakub, Storr, Martin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389673/ https://www.ncbi.nlm.nih.gov/pubmed/22783191 http://dx.doi.org/10.3389/fphar.2012.00127 |
Ejemplares similares
-
IBS-Symptoms in IBD Patients—Manifestation of Concomitant or Different Entities
por: Szałwińska, Patrycja, et al.
Publicado: (2020) -
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
por: Fichna, Jakub, et al.
Publicado: (2013) -
Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer
por: Michalak, Arkadiusz, et al.
Publicado: (2016) -
Dual Functional Capability of Dendritic Cells – Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy
por: Mosińska, Paula, et al.
Publicado: (2017) -
Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists
por: Mosińska, Paula, et al.
Publicado: (2017)